Clinical Trials Logo
  1. Home
  2. Glaucoma
  3. NCT05954637
  4. Details
NCT05954637 Clinical Trial

Correlation of Structure and Function in Glaucoma

Glaucoma Clinical Trial

Official title:
Correlation of Structure and Function in Glaucoma

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT05954637
Other study ID # struct_funct_glaucoma
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date July 1, 2023
Est. completion date March 2024

Study information
Verified date August 2023
Source Vienna Hospital Association
Contact Pia V Vécsei-Marlovits, MD, MSc, MBA
Phone 0043-1-80110
Email khi.aug@gesundheitsverbund.at
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The aim of the study is to correlate structure and function in patients with glaucoma. To this end, a cross-sectional study unsing perimetry and optical coherence tomography is performed.

Recruitment information / eligibility
Status Recruiting
Enrollment 84
Est. completion date March 2024
Est. primary completion date March 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years to 100 Years
Eligibility Inclusion Criteria: - Diagnosis of glaucomatous optic neuropathy Exclusion Criteria: - Age < 18 years - Diabetes - Pregnancy - Hypertensive retinopathy - Smoking - Intraocular surgery 1 month prior to study entry - Systemic or ocular disease, excluding glaucoma, which the investigator believes could affect the test results - Insufficient quality of the optical coherence tomography imaging - Insufficient cooperation during examinations or measurements

Study Design

Related Conditions & MeSH terms

Intervention

Device:
• Optical coherence tomography
Heidelberg Engineering Spectralis

Locations
Country Name City State
Austria Department of Ophthalmology, Clinic Hietzing, Vienna Healthcare Group Vienna

Sponsors (1)
Lead Sponsor Collaborator
Vienna Hospital Association

Country where clinical trial is conducted

Austria, 

Outcome
Type Measure Description Time frame Safety issue
Primary Association of retinal sensitivity with peripapillary retinal nerve fiber layer thickness 1 day
Primary Association of retinal sensitivity with peripapillary vessel density 1 day
Secondary Glaucoma Activity Limitation score 1 day
See also
  Status Clinical Trial Phase
Recruiting NCT06000865 - Glaucoma Rehabilitation With Action viDeo Games and Exercise - GRADE N/A
Recruiting NCT06278597 - Automatic Evaluation of the Anterior Chamber Angle Width by a New Non-contact Optical Device N/A
Active, not recruiting NCT04271709 - Manhattan Vision Screening and Follow-Up Study (NYC-SIGHT) N/A
Recruiting NCT03274024 - The Asia Primary Tube Versus Trab (TVT) Study N/A
Completed NCT04552964 - Assessment of the Impact of an add-on and Its Smartphone Application on the Daily Management of Glaucoma N/A
Recruiting NCT01957267 - Functional and Structural Imaging for Glaucoma
Active, not recruiting NCT04624698 - iStent Inject New Enrollment Post-Approval Study N/A
Completed NCT04020705 - The Efficacy of Citicoline in Eyedrops (OMK1) in Reducing the Progression of Glaucoma N/A
Completed NCT03150160 - Additive Effect of Twice-daily Brinzolamide 1%/Brimonidine 0.2%Combination as an Adjunctive Therapy to Travoprost in Patients With Normal Tension Glaucoma Phase 4
Not yet recruiting NCT05581498 - Glaucoma Exercise as Medicine Study (GEMS). N/A
Recruiting NCT02921568 - Side-by-Side Comparison of P200TE and Spectral OCT/SLO on Diseased Eyes N/A
Active, not recruiting NCT02901730 - Clinical Study of LPI With Different Laser Wavelengths N/A
Completed NCT02955849 - A Trial of China Laser and Surgery Study Glaucoma in Rural China Early Phase 1
Recruiting NCT02471105 - Investigation of IOP and Tolerability of Bimatoprost 0.01% and Tafluprost Unit Dose Preservative Free 15 Microgram/ml Phase 4
Recruiting NCT02554214 - Pilot Clinical Trial on a New Adjustable Glaucoma Drainage Device N/A
Active, not recruiting NCT02390284 - Stop Retinal Ganglion Cell Dysfunction Study Phase 3
Completed NCT02628223 - 180 Degree vs. 360 Degree Selective Laser Trabeculoplasty as Initial Therapy for Glaucoma N/A
Completed NCT02520674 - Glaucoma Screening With Smartphone Ophthalmology N/A
Completed NCT02246764 - Study of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension Phase 3
Completed NCT02653963 - Triamcinolone for Ahmed Glaucoma Valve N/A